A recent study reported that elevated NEAT1 expression is associated with inflammatory progression in RA patients via the miR-410-3p/YYY1 axis [13], suggesting that NEAT1 may be a potential biomarker and target for diagnosis and treatment of RA patients. The gene discussed is NEAT1; the disease is rheumatoid arthritis.